View All Upcoming Sponsored Webinars
Recorded September 17, 2015
Uncertainty around efficacy, safety, approval, and reimbursement makes drug development riskier than ever. Does your portfolio management process have what it takes to meet the ever-increasing demands of management, the board, and the street? In this webinar we’ll review processes, methods and tools that identify high-value portfolios in alignment with multiple, conflicting strategic goals, such as short- and long-term revenue.
Richard Sonnenblick, Ph.D.
Richard Sonnenblick, the CEO of Enrich Consulting, has been with Enrich since its inception in 1998. The vision he brought to Enrich has been realized in the Enrich Analytics Platform. Prior to founding Enrich, he built a decision analysis consulting practice at Lumina Decision Systems, where he worked on integrated assessments of environmental legislation and R&D valuation models for high technology firms. Dr. Sonnenblick holds a Ph.D. and MS from Carnegie Mellon University in Engineering and Public Policy, and a BA in Physics from the University of California, Santa Cruz.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesReports & Market Researchbarnett educational servicesHealthtech PublishingKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers